Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036341 (
schizophrenia
)
60,220
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Schizophrenia
is a serious disease of the central nervous system that affects a person's ability to think, feel and behave clearly. Even though the pathophysiological hypothesis of the disease is not clearly understood, dysfunction of dopamine, glutamate, serotonin and other neurotransmitters is widely believed to be involved. Serotonin within the synaptic vesicles functions as neurotransmitter and neurohormone in regulation of emotion, learning, memory, hormone release, cognition and motor function. Dysfunction of normal brain activity of serotonin is associated with
schizophrenia
. The role of serotonin 6 and 7 receptors in
schizophrenia
, interaction with neurotransmitters and the effect of drugs on those receptors in
schizophrenia
are the goal of this review. The aim of this review was to provide information for researchers and other scholars to identify the possible intervention points in the management of
schizophrenia
. The serotonin 6 and 7 receptors are associated with
schizophrenia
via modulating cyclic adenosine monophosphate, regulation of Fyn kinase and induction of structural plasticity. The above modulatory effects affect cholinergic, dopaminergic, glutamatergic, adrenergic and GABAergic systems. Recently, diverse numbers of selective agonist and antagonist ligands were developed for both receptors. SGS-518, ABT-354, Lu AE58054, SB-742,457, S-518, AVN-211, AVN-322, SYN-114 and SYN-120 are
serotonin 6 receptor
antagonists and aripiprazole-controlled release serotonin 7 receptor agonists under clinical trial for
schizophrenia
. Thus, research on novel drugs that act on serotonin 6 and 7 receptors likely facilitates the intervention into
schizophrenia
patients seeking better quality of life in the future.
...
PMID:Serotonin Type 6 and 7 Receptors as a Novel Therapeutic Target for the Treatment of Schizophrenia. 3314 91
<< Previous
1
2
3
4
5
6
7